Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Downsizes GeneShield Unit

NEW YORK, May 30 -- Orchid BioSciences has downsized and reorganized its GeneShield business unit, the company said today.


As part of the consolidation, the company laid off fewer than 25 staff, according to an Orchid spokesperson.


GeneShield's RxShield program -- an information service on genetic variability targeting physicians and patients that is slated for commercial launch this year, according to the company website -- will now be more targeted.  "As opposed to launching a broad-base panel, this is focusing on particular conditions or therapeutic groups," the spokesperson said. Orchid GeneShield expects to reduce its operating costs as a result.


Orchid will provide more details on GeneShield's consolidation on August 7, when it plans to announce its second quarter results.


For further information, see the company statement.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.